(Q36336929)

13 August 2017

Microanalysis of the antiretroviral nevirapine in human hair from HIV-infected patients by liquid chromatography-tandem mass spectrometry (English)

1 reference

13 August 2017

0 references

anti-retroviral agent

0 references

nevirapine

1 reference

liquid chromatography-tandem mass spectrometry

inferred from title

1 reference

Yong Huang

1

1 reference

13 August 2017

Qiyun Yang

2

1 reference

13 August 2017

Kwangchae Yoon

3

1 reference

13 August 2017

Yvonne Lei

4

1 reference

13 August 2017

Robert Shi

5

1 reference

13 August 2017

Winnie Gee

6

1 reference

13 August 2017

Emil T Lin

7

1 reference

13 August 2017

Ruth M Greenblatt

8

1 reference

13 August 2017

Monica Gandhi

9

1 reference

13 August 2017

language of work or name

English

0 references

publication date

17 August 2011

1 reference

Analytical and Bioanalytical Chemistry

13 August 2017

1 reference

13 August 2017

401

1 reference

13 August 2017

6

1 reference

13 August 2017

1923-1933

1 reference

describes a project that uses

13 August 2017

liquid chromatography-tandem mass spectrometry

1 reference

https://scigraph.springernature.com/pub.10.1007/s00216-011-5278-7

inferred from title

exact match

0 references

cites work

Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477620

Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477620

A glowing future for dried blood spot sampling.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477620

Hepatotoxicity associated with long- versus short-course HIV-prophylactic nevirapine use: a systematic review and meta-analysis from the Research on Adverse Drug events And Reports (RADAR) project.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477620

Protease inhibitor levels in hair strongly predict virologic response to treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477620

Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477620

Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477620

An update on therapeutic drug monitoring for antiretroviral drugs

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477620

30 September 2017

Adherence to Medication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477620

Integrating HIV prevention and treatment: from slogans to impact

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477620

Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477620

Prevention of Mother-to-Child Transmission of HIV-What Next?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477620

Therapeutic drug monitoring in HIV infection: current status and future directions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477620

Hair as a biological specimen for therapeutic drug monitoring

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477620

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477620

Hair analysis for abused and therapeutic drugs

30 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477620

30 September 2017

https://api.crossref.org/works/10.1007%2FS00216-011-5278-7

Do we still need a cohort study of women with HIV infection?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477620

Adherence in AIDS clinical trials: a framework for clinical research and clinical care

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477620

Therapeutic drug monitoring in hair samples. Principles and practice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477620

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477620

"White coat compliance" limits the reliability of therapeutic drug monitoring in HIV-1-infected patients

30 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5278-7

Treatment failure of nelfinavir-containing triple therapy can largely be explained by low nelfinavir plasma concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5278-7

PharmAdapt: a randomized prospective study to evaluate the benefit of therapeutic monitoring of protease inhibitors: 12 week results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5278-7

Hair it is: the long and short of monitoring antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5278-7

Relationship between levels of indinavir in hair and virologic response to highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5278-7

Indinavir hair concentration in highly active antiretroviral therapy-treated patients: association with viral load and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5278-7

Low trough plasma concentrations of nevirapine associated with virologic rebounds in HIV-infected patients who switched from protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5278-7

Liver toxicity caused by nevirapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5278-7

Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5278-7

The application of dried blood spot sampling in global clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5278-7

Pharmacologic optimization of protease inhibitors and nonnucleoside reverse transcriptase inhibitors (POPIN)--a randomized controlled trial of therapeutic drug monitoring and adherence support

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477620

Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477620

Patient compliance and drug failure in protease inhibitor monotherapy

22 September 2018

1 reference

12 December 2020

The Women's Interagency HIV Study. WIHS Collaborative Study Group

1 reference

12 December 2020

Marked intraindividual variability in antiretroviral concentrations may limit the utility of therapeutic drug monitoring

1 reference

12 December 2020

Hair versus plasma concentrations as indicator of indinavir exposure in HIV-1-infected patients treated with indinavir/ritonavir combination

1 reference

12 December 2020

10.1007/S00216-011-5278-7

Identifiers

DOI

1 reference

13 August 2017

1 reference

13 August 2017

1 reference